메뉴 건너뛰기




Volumn 3, Issue 3, 2014, Pages 710-718

Modeling tandem AAG8-MEK inhibition in melanoma cells

Author keywords

AAG8; Drug combination; Drug resistance; MEK; Melanoma

Indexed keywords

AGING ASSOCIATED GENE 8 ANTAGONIST; AGING ASSOCIATED GENE 8 PROTEIN; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; BD 1063; CHAPERONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; PD 901; RAF PROTEIN; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN KINASE INHIBITOR; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

EID: 84925547739     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.233     Document Type: Article
Times cited : (3)

References (27)
  • 2
    • 82555205202 scopus 로고    scopus 로고
    • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
    • Bertolotto, C., F. Lesueur, S. Giuliano, T. Strub, M. de Lichy, K. Bille, et al. 2011. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480: 94-98.
    • (2011) Nature , vol.480 , pp. 94-98
    • Bertolotto, C.1    Lesueur, F.2    Giuliano, S.3    Strub, T.4    de Lichy, M.5    Bille, K.6
  • 3
    • 79953056443 scopus 로고    scopus 로고
    • The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
    • Ceol, C. J., Y. Houvras, J. Jane-Valbuena, S. Bilodeau, D. A. Orlando, V. Battisti, et al. 2011. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471:513-517.
    • (2011) Nature , vol.471 , pp. 513-517
    • Ceol, C.J.1    Houvras, Y.2    Jane-Valbuena, J.3    Bilodeau, S.4    Orlando, D.A.5    Battisti, V.6
  • 4
    • 79953064886 scopus 로고    scopus 로고
    • DHODH modulates transcriptional elongation in the neural crest and melanoma
    • White, R. M., J. Cech, S. Ratanasirintrawoot, C. Y. Lin, P. B. Rahl, C. J. Burke, et al. 2011. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471:518-522.
    • (2011) Nature , vol.471 , pp. 518-522
    • White, R.M.1    Cech, J.2    Ratanasirintrawoot, S.3    Lin, C.Y.4    Rahl, P.B.5    Burke, C.J.6
  • 5
    • 80054681545 scopus 로고    scopus 로고
    • In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma
    • Karreth, F. A., Y. Tay, D. Perna, U. Ala, S. M. Tan, A. G. Rust, et al. 2011. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147:382-395.
    • (2011) Cell , vol.147 , pp. 382-395
    • Karreth, F.A.1    Tay, Y.2    Perna, D.3    Ala, U.4    Tan, S.M.5    Rust, A.G.6
  • 6
    • 79960064599 scopus 로고    scopus 로고
    • miR-30b/30d regulation of GaINAc transferases enhances invasion and immunosuppression during metastasis
    • Gaziel-Sovran, A., M. F. Segura, R. Di Micco, M. K. Collins, D. Hanniford, E. V. S. de Miera, et al. 2011. miR-30b/30d regulation of GaINAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20:104-118.
    • (2011) Cancer Cell , vol.20 , pp. 104-118
    • Gaziel-Sovran, A.1    Segura, M.F.2    Di Micco, R.3    Collins, M.K.4    Hanniford, D.5    de Miera, E.V.S.6
  • 7
    • 84873728334 scopus 로고    scopus 로고
    • Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
    • Das Thakur, M., F. Salangsang, A. S. Landman, W. R. Sellers, N. K. Pryer, M. P. Levesque, et al. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature 2013;494: 251-255.
    • (2013) Nature , vol.494 , pp. 251-255
    • Das Thakur, M.1    Salangsang, F.2    Landman, A.S.3    Sellers, W.R.4    Pryer, N.K.5    Levesque, M.P.6
  • 8
    • 84867685827 scopus 로고    scopus 로고
    • Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
    • Landsberg, J., J. Kohlmeyer, M. Renn, T. Bald, M. Rogava, M. Cron, et al. 2012. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490:412-416.
    • (2012) Nature , vol.490 , pp. 412-416
    • Landsberg, J.1    Kohlmeyer, J.2    Renn, M.3    Bald, T.4    Rogava, M.5    Cron, M.6
  • 9
    • 84872567654 scopus 로고    scopus 로고
    • Dynamic interaction between Sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine
    • Kourrich, S., T. Hayashi, J. Y. Chuang, S. Y. Tsai, T. P. Su, and A. Bonci 2013. Dynamic interaction between Sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247.
    • (2013) Cell , vol.152 , pp. 236-247
    • Kourrich, S.1    Hayashi, T.2    Chuang, J.Y.3    Tsai, S.Y.4    Su, T.P.5    Bonci, A.6
  • 10
    • 84155163741 scopus 로고    scopus 로고
    • A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
    • Al-Saif, A., F. Al-Mohanna, and S. Bohlega 2011. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70:913-919.
    • (2011) Ann. Neurol. , vol.70 , pp. 913-919
    • Al-Saif, A.1    Al-Mohanna, F.2    Bohlega, S.3
  • 11
    • 84869234106 scopus 로고    scopus 로고
    • Sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation
    • Marriott, K. S. C., M. Prasad, V. Thapliyal, and H. S. Bose 2012. Sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation. J. Pharmacol. Exp. Ther. 343:578-586.
    • (2012) J. Pharmacol. Exp. Ther. , vol.343 , pp. 578-586
    • Marriott, K.S.C.1    Prasad, M.2    Thapliyal, V.3    Bose, H.S.4
  • 12
    • 84870736640 scopus 로고    scopus 로고
    • Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens
    • Wang, L. X., J. A. Eldred, P. Sidaway, J. Sanderson, A. J. O. Smith, R. P. Bowater, et al. 2012. Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens. Mech. Ageing Dev. 133:665-674.
    • (2012) Mech. Ageing Dev. , vol.133 , pp. 665-674
    • Wang, L.X.1    Eldred, J.A.2    Sidaway, P.3    Sanderson, J.4    Smith, A.J.O.5    Bowater, R.P.6
  • 13
    • 84879392732 scopus 로고    scopus 로고
    • Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappa B pathway
    • Hyrskyluoto, A., I. Pulli, K. Tornqvist, T. H. Ho, L. Korhonen, and D. Lindholm 2013. Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappa B pathway. Cell Death Dis. 4:e646.
    • (2013) Cell Death Dis. , vol.4
    • Hyrskyluoto, A.1    Pulli, I.2    Tornqvist, K.3    Ho, T.H.4    Korhonen, L.5    Lindholm, D.6
  • 15
    • 34247864012 scopus 로고    scopus 로고
    • Three-dimensional culture models of normal and malignant breast epithelial cells
    • Lee, G. Y., P. A. Kenny, E. H. Lee, and M. J. Bissell 2007. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4:359-365.
    • (2007) Nat. Methods , vol.4 , pp. 359-365
    • Lee, G.Y.1    Kenny, P.A.2    Lee, E.H.3    Bissell, M.J.4
  • 16
    • 84863982875 scopus 로고    scopus 로고
    • SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
    • Montagner, M., E. Enzo, M. Forcato, F. Zanconato, A. Parenti, E. Rampazzo, et al. 2012. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487:380-384.
    • (2012) Nature , vol.487 , pp. 380-384
    • Montagner, M.1    Enzo, E.2    Forcato, M.3    Zanconato, F.4    Parenti, A.5    Rampazzo, E.6
  • 17
    • 27144537768 scopus 로고    scopus 로고
    • Novel genes associated with malignant melanoma but not benign melanocytic lesions
    • Talantov, D., A. Mazumder, J. X. Yu, T. Briggs, Y. Q. Jiang, J. Backus, et al. 2005. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11:7234-7242.
    • (2005) Clin. Cancer Res. , vol.11 , pp. 7234-7242
    • Talantov, D.1    Mazumder, A.2    Yu, J.X.3    Briggs, T.4    Jiang, Y.Q.5    Backus, J.6
  • 20
    • 84884127318 scopus 로고    scopus 로고
    • Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
    • Hatzivassiliou, G., J. R. Haling, H. F. Chen, K. Song, S. Price, R. Heald, et al. 2013. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature 501:232-236.
    • (2013) Nature , vol.501 , pp. 232-236
    • Hatzivassiliou, G.1    Haling, J.R.2    Chen, H.F.3    Song, K.4    Price, S.5    Heald, R.6
  • 21
    • 84883311219 scopus 로고    scopus 로고
    • Allosteric activation of functionally asymmetric RAF kinase dimers
    • Hu, J. C., E. C. Stites, H. Y. Yu, E. A. Germino, H. S. Meharena, P. J. S. Stork, et al. 2013. Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154:1036-1046.
    • (2013) Cell , vol.154 , pp. 1036-1046
    • Hu, J.C.1    Stites, E.C.2    Yu, H.Y.3    Germino, E.A.4    Meharena, H.S.5    Stork, P.J.S.6
  • 22
    • 83455254767 scopus 로고    scopus 로고
    • RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
    • Poulikakos, P. I., Y. Persaud, M. Janakiraman, X. J. Kong, C. Ng, G. Moriceau, et al. 2011. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480:387-390.
    • (2011) Nature , vol.480 , pp. 387-390
    • Poulikakos, P.I.1    Persaud, Y.2    Janakiraman, M.3    Kong, X.J.4    Ng, C.5    Moriceau, G.6
  • 23
    • 84871961245 scopus 로고    scopus 로고
    • Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
    • Ferguson, J., I. Arozarena, M. Ehrhardt, and C. Wellbrock 2013. Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene 32:86-96.
    • (2013) Oncogene , vol.32 , pp. 86-96
    • Ferguson, J.1    Arozarena, I.2    Ehrhardt, M.3    Wellbrock, C.4
  • 24
    • 78650309875 scopus 로고    scopus 로고
    • COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
    • Johannessen, C. M., J. S. Boehm, S. Y. Kim, S. R. Thomas, L. Wardwell, L. A. Johnson, et al. 2010. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468:968-972.
    • (2010) Nature , vol.468 , pp. 968-972
    • Johannessen, C.M.1    Boehm, J.S.2    Kim, S.Y.3    Thomas, S.R.4    Wardwell, L.5    Johnson, L.A.6
  • 25
    • 84890432985 scopus 로고    scopus 로고
    • p53 status determines the role of autophagy in pancreatic tumour development
    • Rosenfeldt, M. T., J. O'Prey, J. P. Morton, C. Nixon, G. MacKay, A. Mrowinska, et al. 2013. p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296-300.
    • (2013) Nature , vol.504 , pp. 296-300
    • Rosenfeldt, M.T.1    O'Prey, J.2    Morton, J.P.3    Nixon, C.4    MacKay, G.5    Mrowinska, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.